GS

The Goldman Sachs Group, Inc.

64
Fundamentals69/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential14/ 100

GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.

HCMA

HCM III Acquisition Corp.

There isn't enough reported data to score HCMA yet.

GS Fundamentals

MetricStatus
Strong
Strong
N/A
N/A

GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.

HCMA Fundamentals

MetricStatus
Unavailable
Healthy
N/A
N/A

HCMA's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like HCMA.

GS PE Valuation

CHEAPFAIREXPENSIVE5.2x10x16x21x
CHEAPFAIREXPENSIVE5.2x10x16x21x
LevelPEPriceVs current
Cheap7.6x$528-42%
Current13x$914—
Forward13x$914—
Fair14x$940+2.9%
Expensive17x$1,214+33%

Historical ranges are pointers, not guarantees.

GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.

HCMA PE Valuation

CHEAPFAIREXPENSIVE48x96x145x193x
CHEAPFAIREXPENSIVE48x96x145x193x
LevelPEPriceVs current
Cheap63x$10.04-2.9%
Current63x$10.34—
Fair96x$15.30+48%
Expensive184x$29.47+185%

Historical ranges are pointers, not guarantees.

HCMA has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.

GS Forward outlook

MetricOutlook
Stable
Strong growth
Growth
Strongly improving
Limited
Low

Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.

HCMA Forward outlook

There aren't enough analyst estimates for HCMA to show an outlook.

GS Risk to reward

ScenarioChangePrice
Upside+19%$1,085.26
Downside-14%$781.84

Calculated from the latest close: $913.60 on Nov 12.

There is not enough scenario data to compare GS and HCMA's risk to reward.

HCMA Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $10.34 on Nov 12.

There is not enough scenario data to compare GS and HCMA's risk to reward.

GS Earnings Per Share

Q4 2023: $22.87Q1 2024: $25.66Q2 2024: $31.20Q3 2024: $34.13Q4 2024: $40.54Q1 2025: $43.08Q2 2025: $45.37Q3 2025: $49.22Q4 2025: $51.32Q1 2026: $54.75Q2 2026: $64.82Q3 2026: $69.58Forward: $72.35
Q4 2023: $22.87Q1 2024: $25.66Q2 2024: $31.20Q3 2024: $34.13Q4 2024: $40.54Q1 2025: $43.08Q2 2025: $45.37Q3 2025: $49.22Q4 2025: $51.32Q1 2026: $54.75Q2 2026: $64.82Q3 2026: $69.58Forward: $72.35
QuarterTTM EPSYoY
Forward$72.35+4%
Q3 2026$69.58+41%
Q2 2026$64.82+43%
Q1 2026$54.75+27%
Q4 2025$51.32+27%
Q3 2025$49.22+44%
Q2 2025$45.37+45%
Q1 2025$43.08+68%
Q4 2024$40.54+77%

GS has the edge over HCMA in the latest year-over-year earnings comparison.

HCMA Earnings Per Share

Q2 2022: $0.55Q3 2022: $0.64Q4 2025: $0.06Q1 2026: $0.11Q2 2026: $0.16
Q2 2022: $0.55Q3 2022: $0.64Q4 2025: $0.06Q1 2026: $0.11Q2 2026: $0.16

HCMA earned $0.16 per share over the past year, down 71% from the year before.

GS Quarterly Revenue

Q4 2023: $11.3BQ1 2024: $14.2BQ2 2024: $12.7BQ3 2024: $12.7BQ4 2024: $13.9BQ1 2025: $15.1BQ2 2025: $14.6BQ3 2025: $15.2BQ4 2025: $13.5BQ1 2026: $17.2BQ2 2026: $20.3BQ3 2026: $18.7B
Q4 2023: $11.3BQ1 2024: $14.2BQ2 2024: $12.7BQ3 2024: $12.7BQ4 2024: $13.9BQ1 2025: $15.1BQ2 2025: $14.6BQ3 2025: $15.2BQ4 2025: $13.5BQ1 2026: $17.2BQ2 2026: $20.3BQ3 2026: $18.7B
QuarterRevenueYoY
Q3 2026$18.7B+23%
Q2 2026$20.3B+39%
Q1 2026$17.2B+14%
Q4 2025$13.5B-3%
Q3 2025$15.2B+20%
Q2 2025$14.6B+15%
Q1 2025$15.1B+6%
Q4 2024$13.9B+23%

GS has the edge over HCMA on sales, with more consistent year-over-year improvement.

HCMA Quarterly Revenue

Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q2 2025: $0Q2 2025: --Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q2 2025: $0Q2 2025: --Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0

HCMA's revenue is shrinking: $0 last quarter.

GS Free Cash Flow

Q4 2023: −$28.9BQ1 2024: −$28.5BQ2 2024: $5.6BQ3 2024: −$38.5BQ4 2024: $46.2BQ1 2025: −$37.7BQ2 2025: $5.2BQ3 2025: $2.1BQ4 2025: −$16.8BQ1 2026: −$32.4BQ2 2026: $5.6BQ3 2026: $3.7B
Q4 2023: −$28.9BQ1 2024: −$28.5BQ2 2024: $5.6BQ3 2024: −$38.5BQ4 2024: $46.2BQ1 2025: −$37.7BQ2 2025: $5.2BQ3 2025: $2.1BQ4 2025: −$16.8BQ1 2026: −$32.4BQ2 2026: $5.6BQ3 2026: $3.7B
QuarterFree cash flowYoY
Q3 2026$3.7B+72%
Q2 2026$5.6B+7.8%
Q1 2026-$32.4B+$5.3B
Q4 2025-$16.8B-136%
Q3 2025$2.1B+$40.6B
Q2 2025$5.2B-6.8%
Q1 2025-$37.7B-$9.2B
Q4 2024$46.2B+$75.1B

HCMA has the stronger cash trend. Its trailing FCF is down 141% versus its history, compared with GS at down 278%.

HCMA Free Cash Flow

Q2 2022: −$100,141Q3 2022: −$101,458Q4 2022: −$177,198Q1 2023: −$255,316Q2 2023: −$340,366Q3 2023: −$447,637Q2 2025: --Q2 2025: --Q3 2025: −$1MQ4 2025: $956,528Q1 2026: --Q2 2026: −$1M
Q2 2022: −$100,141Q3 2022: −$101,458Q4 2022: −$177,198Q1 2023: −$255,316Q2 2023: −$340,366Q3 2023: −$447,637Q2 2025: --Q2 2025: --Q3 2025: −$1MQ4 2025: $956,528Q1 2026: --Q2 2026: −$1M
QuarterFree cash flowYoY
Q3 2023-$447.6K-$346.2K
Q2 2023-$340.4K-$240.2K
Q1 2023-$255.3K+$256.1K
Q4 2022-$177.2K-$176.2K
Q3 2022-$101.5K-$98.2K
Q2 2022-$100.1K-$100.1K
Q1 2022-$511.4K-$503.9K

HCMA's free cash flow was −$2M over the past year, against −$874,338 the year before. Free cash flow isn't a meaningful measure for financial services companies like HCMA.

GS Total Shares

Q4 2023: 346MQ1 2024: 340MQ2 2024: 336MQ3 2024: 331MQ4 2024: 334MQ1 2025: 325MQ2 2025: 318MQ3 2025: 315MQ4 2025: 318MQ1 2026: 308MQ2 2026: 305MQ3 2026: 301M
Q4 2023: 346MQ1 2024: 340MQ2 2024: 336MQ3 2024: 331MQ4 2024: 334MQ1 2025: 325MQ2 2025: 318MQ3 2025: 315MQ4 2025: 318MQ1 2026: 308MQ2 2026: 305MQ3 2026: 301M
PeriodChange %Net change
Quarterly-1.2%-3.8M shares
1 year-4.4%-13.9M shares
3 years-12%-42.8M shares
5 years-15%-52.8M shares
Available history-20%-74.4M shares

GS has the edge over HCMA on shareholder dilution, with a more favorable share count trend.

HCMA Total Shares

Q2 2022: 39MQ3 2022: 39MQ1 2023: 39MQ2 2023: 20MQ3 2023: 14MQ2 2025: 29MQ2 2025: 7MQ3 2025: 34MQ4 2025: 34MQ1 2026: 34MQ2 2026: 34M
Q2 2022: 39MQ3 2022: 39MQ1 2023: 39MQ2 2023: 20MQ3 2023: 14MQ2 2025: 29MQ2 2025: 7MQ3 2025: 34MQ4 2025: 34MQ1 2026: 34MQ2 2026: 34M
PeriodChange %Net change
Quarterly0%--
1 year+360%+26.4M shares
3 years-13%-5.1M shares

HCMA has 34M diluted shares, up 360% from a year ago.

GS Net Leverage

Q4 2023: -9.6xQ1 2024: -6.8xQ2 2024: -6.5xQ3 2024: -3.5xQ4 2024: -4.7xQ1 2025: -3.9xQ2 2025: -3.1xQ3 2025: -3.5xQ4 2025: -6.4xQ1 2026: -6.7xQ2 2026: -6.1xQ3 2026: -5.4x
Q4 2023: -9.6xQ1 2024: -6.8xQ2 2024: -6.5xQ3 2024: -3.5xQ4 2024: -4.7xQ1 2025: -3.9xQ2 2025: -3.1xQ3 2025: -3.5xQ4 2025: -6.4xQ1 2026: -6.7xQ2 2026: -6.1xQ3 2026: -5.4x
QuarterNet LeverageStatus
Q3 2026-5.4xNet Cash
Q2 2026-6.1xNet Cash
Q1 2026-6.7xNet Cash
Q4 2025-6.4xNet Cash
Q3 2025-3.5xNet Cash
Q2 2025-3.1xNet Cash
Q1 2025-3.9xNet Cash
Q4 2024-4.7xNet Cash

GS has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like GS.

HCMA Net Leverage

GS Weekly Momentum

MetricValueStatus
RSI44.5Neutral
Stochastic16.3Oversold

GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).

HCMA Weekly Momentum

MetricValueStatus
RSI64.3Neutral
Stochastic86.7Overbought

HCMA's weekly RSI is 64 (neutral) and its Stochastic is 87 (overbought).

GS PE vs Financial Services Sector

MetricGSSector medianRelative
PE13x13x0.8% above
PE %466317 pts below

GS has the edge over HCMA on valuation relative to its sector.

HCMA PE vs Financial Services Sector

MetricHCMASector medianRelative
PE63x13x384% above
PE %431033 pts above

HCMA is trading at 63x earnings, a 384% premium to the Financial Services sector's median of 13x, though its earnings don't support one.

GS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$895.52% above
20 week MA$977.46.5% below
50 week MA$945.43.4% below
100 week MA$804.514% above
200 week MA$602.752% above

HCMA has stronger trend alignment. GS is above 3 of 5 weekly averages versus HCMA above 3 of 3.

HCMA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$10.30.3% above
20 week MA$10.30.4% above
50 week MA$10.21.3% above

HCMA is in an uptrend: it's above all three of its weekly moving averages, and 1.3% above its 50-week average.

GS Yearly ROI

YearStart priceEnd priceROI
2020$230.7$256.2+11%
2021$256.2$385.0+50%
2022$385.0$345.5-10%
2023$345.5$385.8+12%
2024$385.8$576.2+49%
2025$576.2$907.0+57%
2026 YTD$907.0$913.6+0.7%

GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.

HCMA Yearly ROI

YearStart priceEnd priceROI
2025$10.1$10.1-0.4%
2026 YTD$10.1$10.3+2.7%

HCMA has the edge over GS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key